Evidence map›Paper›PMID 27995044›Full record

ArticleSpringerPlus2016

A concise drug alerting rule set for Chinese hospitals and its application in computerized physician order entry (CPOE).

Yinsheng Zhang, Xin Long, Weihong Chen, Haomin Li, Huilong Duan, Qian Shang

Abstract read
In one paragraph

Article in SpringerPlus, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yinsheng ZhangSchool of Computer Science and Information Engineering, Zhejiang Gongshang University, Hangzhou, 310018 Zhejiang People's Republic of China.
Xin LongCollege of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, 310027 Zhejiang People's Republic of China.
Weihong ChenDepartment of Pharmacy, DaYi Hospital, Taiyuan, 030012 ShanXi People's Republic of China.
Haomin LiChildren's Hospital, Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou, 310058 Zhejiang People's Republic of China.
Huilong DuanCollege of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, 310027 Zhejiang People's Republic of China.
Qian ShangManagement School, Hangzhou Dianzi University, Hangzhou, 310058 Zhejiang People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA minimized and concise drug alerting rule set can be effective in reducing alert fatigue.

objectivesThis study aims to develop and evaluate a concise drug alerting rule set for Chinese hospitals. The rule set covers not only western medicine, but also Chinese patent medicine that is widely used in Chinese hospitals.

settingA 2600-bed general hospital in China.

methodsIn order to implement the drug rule set in clinical information settings, an information model for drug rules was designed and a rule authoring tool was developed accordingly. With this authoring tool, clinical pharmacists built a computerized rule set that contains 150 most widely used and error-prone drugs. Based on this rule set, a medication-related clinical decision support application was built in CPOE. Drug alert data between 2013/12/25 and 2015/07/01 were used to evaluate the effect of the rule set.

main outcome measureNumber of alerts, number of corrected/overridden alerts, accept/override rate.

resultsTotally 18,666 alerts were fired and 2803 alerts were overridden. Overall override rate is 15.0% (2803/18666) and accept rate is 85.0%.

conclusionsThe rule set has been well received by physicians and can be used as a preliminary medical order screening tool to reduce pharmacists' workload. For Chinese hospitals, this rule set can serve as a starter kit for building their own pharmaceutical systems or as a reference to tier commercial rule set.

Indexed as

Alert fatigueChinese patent medicineDrug alerting ruleMedication-related clinical decision support

Identifiers

PMID27995044
PMCPMC5133218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.